NEW YORK, March 20 (Reuters) - Just weeks after prosecutors accused Forest Laboratories Inc of illegally marketing its anti-depressants Celexa and Lexapro to children and paying pediatricians ...
On April 20, the FDA approved a revision to the safety labeling for citalopram hydrobromide and escitalopram oxalate (Celexa and Lexapro, respectively, made by Forest Laboratories) in tablet and oral ...
In re Celexa And Lexapro – The First Circuit Weighs In On China Agritech And American Pipe Tolling
The Supreme Court meant what it said in China Agritech, Inc. v. Resh – that is the primary lesson from the First Circuit’s January 30 th decision in In re Celexa and Lexapro Marketing and Sales ...
Employees of Forest Labs and that company's rivals should read the U.S. government's complaint against the company, which alleges off-label promotion of Lexapro and Celexa for use in children. The ...
A federal judge in Camden, N.J., has remanded to state court 15 suits over birth defects in children born to mothers who took Forest Laboratories' antidepressants Celexa and Lexapro for lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results